We are live on ! Find out more
TVRD

Tvardi Therapeutics
TVRD

168 hedge funds and large institutions have $703M invested in Tvardi Therapeutics in 2021 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 44 increasing their positions, 48 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

157% more call options, than puts

Call options by funds: $52.7M | Put options by funds: $20.5M

82% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 17

42% more capital invested

Capital invested by funds: $494M → $703M (+$209M)

8% more funds holding

Funds holding: 156 → 168 (+12)

0.02% less ownership

Funds ownership: 1.82% → 1.8% (-0.02%)

8% less repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 48

Holders
168
Holders Change
+12
Holders Change %
+7.69%
% of All Funds
2.95%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
31
Increased
44
Reduced
48
Closed
17
Calls
$52.7M
Puts
$20.5M
Net Calls
+$32.2M
Net Calls Change
+$21.8M

Top Buyers

Rank Fund Capital Flow
1
IC
Ikarian Capital
Texas
+$5.42M
2
N
Nuveen
North Carolina
+$4.57M
3
PCM
Penserra Capital Management
California
+$3.76M
4
Two Sigma Investments
Two Sigma Investments
New York
+$3.52M
5
BCM
Burrage Capital Management
Massachusetts
+$3.42M

Top Sellers

Rank Fund Capital Flow
1
CG
Carmignac Gestion
France
-$11.4M
2
First Manhattan
First Manhattan
New York
-$9.29M
3
EMG
ETF Managers Group
New Jersey
-$6.57M
4
RCP
Rho Capital Partners
New York
-$4.75M
5
PM
Prosight Management
Texas
-$3.69M
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
26
Renaissance Technologies
New York
$5.68M -$328K -479 -6%
DCM
27
DAFNA Capital Management
California
$5.68M – – –
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$5.08M +$1.3M +1,905 +41%
Morgan Stanley
29
Morgan Stanley
New York
$5.06M +$1.94M +2,830 +78%
Citadel Advisors
30
Citadel Advisors
Florida
$4.71M +$474K +692 +13%
BCM
31
Burrage Capital Management
Massachusetts
$3.91M +$3.42M +5,000 New
Deutsche Bank
32
Deutsche Bank
Germany
$3.9M +$2.83M +4,128 +482%
Adage Capital Partners
33
Adage Capital Partners
Massachusetts
$3.8M +$3.33M +4,865 New
Janus Henderson Group
34
Janus Henderson Group
United Kingdom
$3.7M +$3.24M +4,735 New
Bank of New York Mellon
35
Bank of New York Mellon
New York
$3.68M -$164K -239 -5%
LPL Financial
36
LPL Financial
California
$3.24M -$16.4K -24 -0.6%
Wells Fargo
37
Wells Fargo
California
$3.16M +$359K +525 +15%
State of New Jersey Common Pension Fund D
38
State of New Jersey Common Pension Fund D
New Jersey
$2.41M -$806K -1,177 -28%
WSCM
39
Wellington Shields Capital Management
New York
$2.36M +$2.06M +3,015 New
Swiss National Bank
40
Swiss National Bank
Switzerland
$2.35M +$141K +206 +7%
PM
41
Prosight Management
Texas
$2.17M -$3.69M -5,390 -66%
CM
42
Caption Management
Oklahoma
$2.07M +$1.81M +2,650 New
Stifel Financial
43
Stifel Financial
Missouri
$1.97M -$22.6K -33 -1%
JP Morgan Chase
44
JP Morgan Chase
New York
$1.87M -$236K -344 -13%
California Public Employees Retirement System
45
California Public Employees Retirement System
California
$1.81M – – –
CCMW
46
Cypress Capital Management (Wyoming)
Wyoming
$1.57M -$170K -248 -11%
PP
47
PDT Partners
New York
$1.41M -$147K -214 -11%
Marshall Wace
48
Marshall Wace
United Kingdom
$1.39M +$1.22M +1,781 New
Assenagon Asset Management
49
Assenagon Asset Management
Luxembourg
$1.39M +$543K +793 +81%
Dimensional Fund Advisors
50
Dimensional Fund Advisors
Texas
$1.37M -$103K -150 -8%
1
2
3 4 5

TVRD Hedge Fund Activity: Q1 2021 in Review

168 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Tvardi Therapeutics (TVRD) for Q1 2021, worth a combined $703M — up 42% from $494M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new TVRD positions and 17 closed out — a net gain of 14 holders — while 44 added to existing stakes and 48 trimmed.

The largest buyer was Ikarian Capital, adding an estimated $5.42M. The largest seller was Carmignac Gestion, cutting an estimated $11.4M.

  • 168 institutional investors held Tvardi Therapeutics (TVRD) as of Q1 2021, up from 156 in Q4 2020.
  • Funds reported $703M of Tvardi Therapeutics stock for Q1 2021, up 42% quarter-over-quarter.
  • 31 funds opened new Tvardi Therapeutics positions in Q1 2021 and 17 closed out, a net change of +14 holders.
  • The largest Tvardi Therapeutics buyer in Q1 2021 was Ikarian Capital, an estimated $5.42M added.
  • The largest Tvardi Therapeutics seller in Q1 2021 was Carmignac Gestion, an estimated $11.4M sold.

Based on aggregated 13F filings for Q1 2021.